Literature DB >> 21901209

Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice.

Giada Sebastiani1, Kostas Pantopoulos.   

Abstract

In healthy subjects, the rate of dietary iron absorption, as well as the amount and distribution of body iron are tightly controlled by hepcidin, the iron regulatory hormone. Disruption of systemic iron homeostasis leads to pathological conditions, ranging from anemias caused by iron deficiency or defective iron traffic, to iron overload (hemochromatosis). Other iron-related disorders are caused by misregulation of cellular iron metabolism, which results in local accumulation of the metal in mitochondria. Brain iron overload is observed in neurodegenerative disorders. Secondary hemochromatosis develops as a complication of another disease. For example, repeated blood transfusions, a standard treatment of various anemias characterized by ineffective erythropoiesis, promote transfusional siderosis, while chronic liver diseases are often associated with mild to moderate secondary iron overload. In this critical review, we discuss pathophysiological and clinical aspects of all types of iron metabolism disorders (265 references). This journal is © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901209     DOI: 10.1039/c1mt00082a

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  22 in total

1.  Electrophoretic mobility shift assay (EMSA) for the study of RNA-protein interactions: the IRE/IRP example.

Authors:  Carine Fillebeen; Nicole Wilkinson; Kostas Pantopoulos
Journal:  J Vis Exp       Date:  2014-12-03       Impact factor: 1.355

2.  Rapid elevation of transferrin saturation and serum hepcidin concentration in hemodialysis patients after intravenous iron infusion.

Authors:  Natalia Kitsati; Dimitrios Liakos; Eleni Ermeidi; Michalis D Mantzaris; Spyros Vasakos; Eleni Kyratzopoulou; Petros Eliadis; Emilios Andrikos; Elisavet Kokkolou; Georgios Sferopoulos; Avgi Mamalaki; Konstantinos Siamopoulos; Dimitrios Galaris
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

3.  Iron overload inhibits late stage autophagic flux leading to insulin resistance.

Authors:  James Won Suk Jahng; Reham Musaibeh Alsaadi; Rengasamy Palanivel; Erfei Song; Victoria Emily Barbosa Hipolito; Hye Kyoung Sung; Roberto Jorge Botelho; Ryan Charles Russell; Gary Sweeney
Journal:  EMBO Rep       Date:  2019-08-23       Impact factor: 8.807

Review 4.  Mechanisms of mammalian iron homeostasis.

Authors:  Kostas Pantopoulos; Suheel Kumar Porwal; Alan Tartakoff; L Devireddy
Journal:  Biochemistry       Date:  2012-07-09       Impact factor: 3.162

5.  New developments and controversies in iron metabolism and iron chelation therapy.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2016-03-26

6.  Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing.

Authors:  Alina Daba; Konstantinos Gkouvatsos; Giada Sebastiani; Kostas Pantopoulos
Journal:  J Mol Med (Berl)       Date:  2012-07-31       Impact factor: 4.599

Review 7.  Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury.

Authors:  Marcelo Farina; Daiana Silva Avila; João Batista Teixeira da Rocha; Michael Aschner
Journal:  Neurochem Int       Date:  2012-12-21       Impact factor: 3.921

Review 8.  Iron Deficiency in Obesity and after Bariatric Surgery.

Authors:  Geir Bjørklund; Massimiliano Peana; Lyudmila Pivina; Alexandru Dosa; Jan Aaseth; Yuliya Semenova; Salvatore Chirumbolo; Serenella Medici; Maryam Dadar; Daniel-Ovidiu Costea
Journal:  Biomolecules       Date:  2021-04-21

9.  Synthesis of biocompatible poly(ɛ-caprolactone)- block-poly(propylene adipate) copolymers appropriate for drug nanoencapsulation in the form of core-shell nanoparticles.

Authors:  Stavroula G Nanaki; Kostas Pantopoulos; Dimitrios N Bikiaris
Journal:  Int J Nanomedicine       Date:  2011-11-22

10.  Should we still use Camitta's criteria for severe aplastic anemia?

Authors:  Hyun Hwa Yoon; Seok Jae Huh; Ji Hyun Lee; Suee Lee; Sung-Hyun Kim; Hyuk Chan Kwon; Hyo-Jin Kim
Journal:  Korean J Hematol       Date:  2012-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.